Expanding the chemical space of 3(5)-functionalized 1,2,4-triazoles

被引:0
作者
Dmytro M. Khomenko
Roman O. Doroshchuk
Yulia M. Ohorodnik
Hanna V. Ivanova
Borys V. Zakharchenko
Ilona V. Raspertova
Oleksandr V. Vaschenko
Alexey V. Dobrydnev
Oleksandr O. Grygorenko
Rostyslav D. Lampeka
机构
[1] Enamine Ltd.,
[2] Taras Shevchenko National University of Kyiv,undefined
来源
Chemistry of Heterocyclic Compounds | 2022年 / 58卷
关键词
acyl hydrazides; 1,2,4-triazoles; alkylation; cyclization; functional groups; regioisomers;
D O I
暂无
中图分类号
学科分类号
摘要
An efficient approach to the gram-scale synthesis of 3(5)-substituted, 1,3- and 1,5-disubstituted 1,2,4-triazole-derived building blocks is described. The key synthetic precursors – 1,2,4-triazole-3(5)-carboxylates (20 examples, 35–89% yield) were prepared from readily available acyl hydrazides and ethyl 2-ethoxy-2-iminoacetate hydrochloride. Further transformations were performed following the convergent synthetic strategy and allowed the preparation of 1,3- and 1,5-disubstituted 1,2,4-triazole-derived esters (16 examples, 25–75% yield), 3(5)-substituted, 1,3- and 1,5-disubstituted carboxylate salts (18 examples, 78–93% yield), amides (5 examples, 82–93% yield), nitriles (5 examples, 30–85% yield), hydrazides (6 examples, 84–89% yield), and hydroxamic acids (3 examples, 73–78% yield). Considering wide applications of the 1,2,4-triazole motif in medicinal chemistry, these compounds are valuable building blocks for lead-oriented synthesis; they have also great potential for coordination chemistry.
引用
收藏
页码:116 / 128
页数:12
相关论文
共 299 条
[1]  
Sidwell RW(1972)undefined Science 177 705-undefined
[2]  
Huffman JH(1989)undefined Clin. Infect. Dis. 11 S750-undefined
[3]  
Khare LGP(2008)undefined J. Gastroenterol. Hepatol. 23 844-undefined
[4]  
Allen B(2021)undefined Sci. Rep. 11 9047-undefined
[5]  
Witkowski RJT(2021)undefined Int. J. Infect. Dis. 104 641-undefined
[6]  
Robins K(2020)undefined Int. J. Antimicrob. Agents 56 408-undefined
[7]  
Huggins JW(2002)undefined N. Engl. J. Med. 347 1447-undefined
[8]  
Martin P(2001)undefined Clin. Infect. Dis. 33 489-undefined
[9]  
Jensen DM(2020)undefined PLoS One 15 241-undefined
[10]  
Mongia A(2018)undefined Infect. Dis. 50 485-undefined